Diabetes Mellitus and Hyperglycemia Management in the Hospitalized Patient

Patricia A. Mackey, Michael D. Whitaker

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Diabetes mellitus and hyperglycemia are common in hospitalized patients. Uncontrolled hyperglycemia during hospitalization is associated with poor outcomes. A glucose goal of 140-180 mg/dL is recommended. Scheduled subcutaneous insulin with basal, prandial, and correction components is preferred for treating diabetes in non-critically ill patients. The pharmacodynamics of insulins differ, and the type of insulin used should match daily glucose excursions. Varying hospital settings may warrant using a particular insulin type to achieve optimal glucose control. Herein we describe approaches to address hyperglycemia in the hospitalized patient on the basis of insulin pharmacodynamic profiles.

Original languageEnglish (US)
Pages (from-to)531-537
Number of pages7
JournalJournal for Nurse Practitioners
Volume11
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Hyperglycemia
Diabetes Mellitus
Insulin
Glucose
Insulins
Meals
Hospitalization

Keywords

  • Basal-bolus insulin
  • Correction insulin
  • Diabetes mellitus
  • Hospitalized patient
  • Hyperglycemia

ASJC Scopus subject areas

  • LPN and LVN
  • Fundamentals and skills

Cite this

Diabetes Mellitus and Hyperglycemia Management in the Hospitalized Patient. / Mackey, Patricia A.; Whitaker, Michael D.

In: Journal for Nurse Practitioners, Vol. 11, No. 5, 01.05.2015, p. 531-537.

Research output: Contribution to journalArticle

Mackey, Patricia A. ; Whitaker, Michael D. / Diabetes Mellitus and Hyperglycemia Management in the Hospitalized Patient. In: Journal for Nurse Practitioners. 2015 ; Vol. 11, No. 5. pp. 531-537.
@article{3b504339edc74e5da7eabc2e59d12e6b,
title = "Diabetes Mellitus and Hyperglycemia Management in the Hospitalized Patient",
abstract = "Diabetes mellitus and hyperglycemia are common in hospitalized patients. Uncontrolled hyperglycemia during hospitalization is associated with poor outcomes. A glucose goal of 140-180 mg/dL is recommended. Scheduled subcutaneous insulin with basal, prandial, and correction components is preferred for treating diabetes in non-critically ill patients. The pharmacodynamics of insulins differ, and the type of insulin used should match daily glucose excursions. Varying hospital settings may warrant using a particular insulin type to achieve optimal glucose control. Herein we describe approaches to address hyperglycemia in the hospitalized patient on the basis of insulin pharmacodynamic profiles.",
keywords = "Basal-bolus insulin, Correction insulin, Diabetes mellitus, Hospitalized patient, Hyperglycemia",
author = "Mackey, {Patricia A.} and Whitaker, {Michael D.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.nurpra.2015.02.016",
language = "English (US)",
volume = "11",
pages = "531--537",
journal = "Journal for Nurse Practitioners",
issn = "1555-4155",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Diabetes Mellitus and Hyperglycemia Management in the Hospitalized Patient

AU - Mackey, Patricia A.

AU - Whitaker, Michael D.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Diabetes mellitus and hyperglycemia are common in hospitalized patients. Uncontrolled hyperglycemia during hospitalization is associated with poor outcomes. A glucose goal of 140-180 mg/dL is recommended. Scheduled subcutaneous insulin with basal, prandial, and correction components is preferred for treating diabetes in non-critically ill patients. The pharmacodynamics of insulins differ, and the type of insulin used should match daily glucose excursions. Varying hospital settings may warrant using a particular insulin type to achieve optimal glucose control. Herein we describe approaches to address hyperglycemia in the hospitalized patient on the basis of insulin pharmacodynamic profiles.

AB - Diabetes mellitus and hyperglycemia are common in hospitalized patients. Uncontrolled hyperglycemia during hospitalization is associated with poor outcomes. A glucose goal of 140-180 mg/dL is recommended. Scheduled subcutaneous insulin with basal, prandial, and correction components is preferred for treating diabetes in non-critically ill patients. The pharmacodynamics of insulins differ, and the type of insulin used should match daily glucose excursions. Varying hospital settings may warrant using a particular insulin type to achieve optimal glucose control. Herein we describe approaches to address hyperglycemia in the hospitalized patient on the basis of insulin pharmacodynamic profiles.

KW - Basal-bolus insulin

KW - Correction insulin

KW - Diabetes mellitus

KW - Hospitalized patient

KW - Hyperglycemia

UR - http://www.scopus.com/inward/record.url?scp=84928574404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928574404&partnerID=8YFLogxK

U2 - 10.1016/j.nurpra.2015.02.016

DO - 10.1016/j.nurpra.2015.02.016

M3 - Article

VL - 11

SP - 531

EP - 537

JO - Journal for Nurse Practitioners

JF - Journal for Nurse Practitioners

SN - 1555-4155

IS - 5

ER -